Location: Home
  • search
  • go
  • Relate News
  • 1/14/2025Ikena and Inmagene Biopharma Agree to Merger Deal
  • 1/14/2025CR Pharma Partners with NAMI to Explore Palbociclib for Alzheimer's Tr...
  • 1/14/2025Biophytis Enters Exclusive Negotiations with a Chinese Pharma Firm to ...
  • 1/14/2025ImmuneOnco Begins Trial of Instil's NSCLC Drug in China
  • 1/14/2025NHSA Hosts Roundtable on Supporting Innovative Drug Development
  • 1/13/2025Vertex, Zai Lab Enter Asian Licensing Pact for Povetacicept
  • 1/13/2025AbbVie and Simcere Zaiming Forge Partnership for a Novel Trispecific A...
  • 1/13/2025Hengruiand Kailera Report Positive Data from Phase 2 Obesity Trial of ...
  • 1/13/2025J&J's Balversa (Erdafitinib) Gains NMPA Approval for Advanced Urotheli...
  • 1/13/2025Livzon Group Discontinues LZM009 PD-1 Program Amid Strategic Rethink ...
  • 1/13/2025Regor Releases Phase 2a Topline Results for GLP-1 RGT-075
  • 1/13/2025Akeso Launches Phase 3 Trial for Ivonescimab (AK112)
  • 1/13/2025Okejian Bio Secures CNY 100M+ in Series A Financing to Advance Innova...
  • 1/13/2025CirCode Receives NMPA IND Approval for HM2002 Injection
  • 1/13/2025Gentize Biopharma Secures ~CNY 100M in Pre-A Financing to Advance Vacc...
  • 1/13/2025China's Dealmaking Slows as India and Other APAC Markets Emerge as Key...
  • 1/13/2025NMPA Announces Package Insert Revision of Human Albumin Injection
  • 1/13/2025Review of New Drugs Approved in China in 2024
  • 1/12/2025Big Pharma Rushes to China for Deal Prospecting Despite Regulatory Unc...
  • 1/12/2025Imunopharm Secures Series E Financing to Support IM19 Commercializatio...
  • 1/12/2025CMS Licensed Dimentia Drug ZUNVEYL from Alpha Cognition
  • 1/12/2025WuXi Biologics Announces Agreement with Candid Therapeutics on Trispec...
  • 1/12/2025New Biotech Startups with Strong China Ties and Investor Backing Launc...
  • 1/12/2025Keymed Biosciences and Timberlyne Therapeutics Forge Exclusive Licensi...
  • 1/12/2025HealZen and SIMM Announce Global Deal with J&J to Advance BTK Degrader
  • 1/12/2025Climb and Mabworks Strike Exclusive Antibody License Deal
  • 1/12/2025Vertex and Zai Lab Announce Strategic Deal for Povetacicept in Greater...
  • 1/12/2025Harbour BioMed Announces License Deal with Windward Bio for HBM9378/SK...
  • 1/12/2025Recent Official and Executive Moves
  • 1/12/2025Moderna Navigates Cautious Expansion Into China Amid Geopolitical Tens...
  • Page:40/786 Total number of articles:23558: [First][<<] [38] [39] [40] [41] [42] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group